Ebos Group (ASX:EBO) Gross Profit : A$1,606 Mil (TTM As of Dec. 2023)

View and export this data going back to 2013. Start your Free Trial

What is Ebos Group Gross Profit?

Ebos Group's gross profit for the six months ended in Dec. 2023 was A$817 Mil. Ebos Group's gross profit for the trailing twelve months (TTM) ended in Dec. 2023 was A$1,606 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. Ebos Group's gross profit for the six months ended in Dec. 2023 was A$817 Mil. Ebos Group's Revenue for the six months ended in Dec. 2023 was A$6,589 Mil. Therefore, Ebos Group's Gross Margin % for the quarter that ended in Dec. 2023 was 12.40%.

Ebos Group had a gross margin of 12.40% for the quarter that ended in Dec. 2023 => No sustainable competitive advantage

During the past 13 years, the highest Gross Margin % of Ebos Group was 12.76%. The lowest was 9.62%. And the median was 10.65%.

Ebos Group Gross Profit Historical Data

The historical data trend for Ebos Group's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ebos Group Gross Profit Chart

Ebos Group Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Gross Profit

Get a 7-Day Free Trial

804.37

922.20

991.31

1,248.26

1,553.00

Ebos Group Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Gross Profit	Get a 7-Day Free Trial															5,292.94	-3,797.05	786.86	789.07	816.97

Competitive Comparison of Ebos Group's Gross Profit

For the Medical Distribution subindustry, Ebos Group's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Ebos Group's Gross Profit Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Ebos Group's Gross Profit distribution charts can be found below:

* The bar in red indicates where Ebos Group's Gross Profit falls into.

Ebos Group Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

Ebos Group's Gross Profit for the fiscal year that ended in Jun. 2023 is calculated as

Gross Profit (A: Jun. 2023 )	=	Revenue	-	Cost of Goods Sold
	=	12173.616	-	10620.62
	=	1,553

Ebos Group's Gross Profit for the quarter that ended in Dec. 2023 is calculated as

Gross Profit (Q: Dec. 2023 )	=	Revenue	-	Cost of Goods Sold
	=	6589.453	-	5772.48
	=	817

Gross Profit for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$1,606 Mil.

Gross Profit is the numerator in the calculation of Gross Margin.

Ebos Group's Gross Margin % for the quarter that ended in Dec. 2023 is calculated as

Gross Margin % (Q: Dec. 2023 )	=	Gross Profit (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	(Revenue - Cost of Goods Sold)	/	Revenue
	=	817	/	6589.453
	=	12.40 %

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.

Ebos Group (ASX:EBO) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Ebos Group had a gross margin of 12.40% for the quarter that ended in Dec. 2023 => No sustainable competitive advantage

Ebos Group Gross Profit Related Terms

Thank you for viewing the detailed overview of Ebos Group's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.

Ebos Group (ASX:EBO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Ebos Group Ltd (ASX:EBO) » Definitions » Gross Profit

Comparable Companies

Traded in Other Exchanges

EBO:New Zealand EJG:Germany

Address

108 Wrights Road, P.O. Box 411, Christchurch, STL, NZL, 8024

Website

https://www.ebosgroup.com

Ebos is the largest pharmaceutical wholesaler and distributor across Australia and New Zealand. It services community pharmacies and hospitals, which contribute around 60% and 30% of revenue respectively. Drug pricing and wholesale margins for PBS medicine are governed by the Australian government's Pharmaceutical Benefits Scheme, or PBS. Wholesale gross margins are capped at 7% for community pharmacy and 10% for hospitals, and ongoing price reform typically results in low single digit revenue growth. Aside from pharma distribution, Ebos operates an animal health product wholesale, manufacturing and retail business, as well as undertaking third party logistics services. These segments are smaller contributors to group revenue but due to the unregulated nature are higher-margin operations.

Ebos Group (ASX:EBO) Headlines

No Headlines